195 related articles for article (PubMed ID: 36674418)
1. Development of a Mitochondrial Targeting Lipid Nanoparticle Encapsulating Berberine.
Hori I; Harashima H; Yamada Y
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674418
[TBL] [Abstract][Full Text] [Related]
2. [Development of the MITO-porter, a nano device for mitochondrial drug delivery via membrane fusion].
Yamada Y
Yakugaku Zasshi; 2014; 134(11):1143-55. PubMed ID: 25366911
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial delivery of bongkrekic acid using a MITO-Porter prevents the induction of apoptosis in human HeLa cells.
Yamada Y; Nakamura K; Furukawa R; Kawamura E; Moriwaki T; Matsumoto K; Okuda K; Shindo M; Harashima H
J Pharm Sci; 2013 Mar; 102(3):1008-15. PubMed ID: 23315986
[TBL] [Abstract][Full Text] [Related]
4. The Use of a Microfluidic Device to Encapsulate a Poorly Water-Soluble Drug CoQ
Hibino M; Yamada Y; Fujishita N; Sato Y; Maeki M; Tokeshi M; Harashima H
J Pharm Sci; 2019 Aug; 108(8):2668-2676. PubMed ID: 30959057
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial Delivery of Doxorubicin Using MITO-Porter Kills Drug-Resistant Renal Cancer Cells via Mitochondrial Toxicity.
Yamada Y; Munechika R; Kawamura E; Sakurai Y; Sato Y; Harashima H
J Pharm Sci; 2017 Sep; 106(9):2428-2437. PubMed ID: 28478130
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial delivery of Coenzyme Q10 via systemic administration using a MITO-Porter prevents ischemia/reperfusion injury in the mouse liver.
Yamada Y; Nakamura K; Abe J; Hyodo M; Haga S; Ozaki M; Harashima H
J Control Release; 2015 Sep; 213():86-95. PubMed ID: 26160304
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial Delivery of an Anticancer Drug Via Systemic Administration Using a Mitochondrial Delivery System That Inhibits the Growth of Drug-Resistant Cancer Engrafted on Mice.
Yamada Y; Munechika R; Satrialdi ; Kubota F; Sato Y; Sakurai Y; Harashima H
J Pharm Sci; 2020 Aug; 109(8):2493-2500. PubMed ID: 32376272
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Mitochondrial Delivery of Vitamin B
Yamada Y; Ishimaru T; Ikeda K; Harashima H
J Pharm Sci; 2022 Feb; 111(2):432-439. PubMed ID: 34478755
[TBL] [Abstract][Full Text] [Related]
9. Berberine suppresses influenza virus-triggered NLRP3 inflammasome activation in macrophages by inducing mitophagy and decreasing mitochondrial ROS.
Liu H; You L; Wu J; Zhao M; Guo R; Zhang H; Su R; Mao Q; Deng D; Hao Y
J Leukoc Biol; 2020 Jul; 108(1):253-266. PubMed ID: 32272506
[TBL] [Abstract][Full Text] [Related]
10. Dual function MITO-Porter, a nano carrier integrating both efficient cytoplasmic delivery and mitochondrial macromolecule delivery.
Yamada Y; Furukawa R; Yasuzaki Y; Harashima H
Mol Ther; 2011 Aug; 19(8):1449-56. PubMed ID: 21694702
[TBL] [Abstract][Full Text] [Related]
11. Delivery of bioactive molecules to the mitochondrial genome using a membrane-fusing, liposome-based carrier, DF-MITO-Porter.
Yamada Y; Harashima H
Biomaterials; 2012 Feb; 33(5):1589-95. PubMed ID: 22105068
[TBL] [Abstract][Full Text] [Related]
12. Enhancement in selective mitochondrial association by direct modification of a mitochondrial targeting signal peptide on a liposomal based nanocarrier.
Yamada Y; Harashima H
Mitochondrion; 2013 Sep; 13(5):526-32. PubMed ID: 23000575
[TBL] [Abstract][Full Text] [Related]
13. Development of Liposomes That Target Axon Terminals Encapsulating Berberine in Cultured Primary Neurons.
Hori I; Harashima H; Yamada Y
Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258060
[TBL] [Abstract][Full Text] [Related]
14. Activation of Mitochondrial Oxygen Consumption Rate by Delivering Coenzyme Q
Sato I; Hibino M; Takeda A; Harashima H; Yamada Y
J Pharm Sci; 2024 Jul; 113(7):1836-1843. PubMed ID: 38325738
[TBL] [Abstract][Full Text] [Related]
15. Glucose-coated Berberine Nanodrug for Glioma Therapy through Mitochondrial Pathway.
Wang S; An J; Dong W; Wang X; Sheng J; Jia Y; He Y; Ma X; Wang J; Yu D; Jia X; Wang B; Yu W; Liu K; Zhao Y; Wu Y; Zhu W; Pan Y
Int J Nanomedicine; 2020; 15():7951-7965. PubMed ID: 33116511
[TBL] [Abstract][Full Text] [Related]
16. Berberine attenuated the cytotoxicity induced by t-BHP via inhibiting oxidative stress and mitochondria dysfunction in PC-12 cells.
Li Z; Jiang T; Lu Q; Xu K; He J; Xie L; Chen Z; Zheng Z; Ye L; Xu K; Zhang H; Hu A
Cell Mol Neurobiol; 2020 May; 40(4):587-602. PubMed ID: 31828466
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the Nanoparticulation Method and Cell-Killing Effect following the Mitochondrial Delivery of Hydrophobic Porphyrin-Based Photosensitizers.
Naganawa R; Zhao H; Takano Y; Maeki M; Tokeshi M; Harashima H; Yamada Y
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673875
[TBL] [Abstract][Full Text] [Related]
18. MITO-Porter for Mitochondrial Delivery and Mitochondrial Functional Analysis.
Yamada Y; Harashima H
Handb Exp Pharmacol; 2017; 240():457-472. PubMed ID: 27830347
[TBL] [Abstract][Full Text] [Related]
19. Validation of a Strategy for Cancer Therapy: Delivering Aminoglycoside Drugs to Mitochondria in HeLa Cells.
Abe J; Yamada Y; Harashima H
J Pharm Sci; 2016 Feb; 105(2):734-740. PubMed ID: 26523487
[TBL] [Abstract][Full Text] [Related]
20. [Targeting mitochondria: innovation from mitochondrial drug delivery system (DDS) to mitochondrial medicine].
Yamada Y; Harashima H
Yakugaku Zasshi; 2012; 132(10):1111-8. PubMed ID: 23037696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
